Skip to content
Peptilyze
Growth hormone axis

Hexarelin studies

305 journal papers mention Hexarelin in the title or abstract. Here are the most cited, the latest, and a few facts about the literature.

Studies range from laboratory work to clinical trials. A paper listed here is not an endorsement and says nothing about whether Hexarelin is safe, effective or approved for any use.

Compare Hexarelin prices, from €18.99 →

Papers
305
296 articles, 9 reviews
Earliest paper
1994
Most papers in 1999 (32)
Open access
22%
free to read somewhere
Reviews
3%
of all papers listed

What kind of studies

Of 291 papers in PubMed that mention Hexarelin in the title or abstract, by the study type PubMed records. Categories overlap, so they do not add up to the total.

  • Randomized controlled trials26
  • Other clinical trials32
  • Meta-analyses and systematic reviews0
  • Other reviews23
  • Case reports1
  • Animal studies only107
  • Studies in humans169

Study types are tags assigned by publishers and PubMed indexers; very new papers are often not tagged yet, and a tag is not a quality rating. Retracted papers are excluded. Source: PubMed (NCBI).

Papers per year

1997 to 2026, peak 32 papers in a year. The latest year may still be incomplete.

1997: 25 papers1998: 30 papers1999: 32 papers2000: 22 papers2001: 22 papers2002: 16 papers2003: 12 papers2004: 8 papers2005: 9 papers2006: 7 papers2007: 5 papers2008: 13 papers2009: 4 papers2010: 4 papers2011: 5 papers2012: 4 papers2013: 5 papers2014: 4 papers2015: 1 papers2016: 2 papers2017: 4 papers2018: 6 papers2019: 4 papers2020: 5 papers2021: 5 papers2022: 1 papers2023: 4 papers2024: 2 papers2025: 0 papers2026: 6 papers19972026

Where it is published

  1. The Journal of Clinical Endocrinology & Metabolism30 papers
  2. Journal of Endocrinological Investigation25 papers
  3. Endocrinology18 papers
  4. Clinical Endocrinology18 papers
  5. European Journal of Endocrinology14 papers

The papers

Most citedName in the title

No papers in this list match the filter.

LatestName in title or abstract

  1. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration

    Aleksander Dominikowski, Zofia Rękoś, Michał Olejarz et al. · Frontiers in Endocrinology · 2026

    ReviewOpen access · CC BY1 citationsRead the open copy →

  2. The CD36-PPARγ Pathway in Metabolic Disorders

    Loïze Maréchal, Maximilien Laviolette, Amélie Rodrigue‐Way et al. · International Journal of Molecular Sciences · 2018

    ReviewOpen access · CC BY171 citationsRead the open copy →

  3. Implications of ghrelin and hexarelin in diabetes and diabetes-associated heart diseases

    Rasha Mosa, Zhen Zhang, Renfu Shao et al. · Endocrine · 2015

    Review20 citations

Each list shows up to 40 papers.See all 305 on OpenAlex. Source: OpenAlex (CC0), journal articles and reviews with a DOI, retractions excluded, refreshed weekly, last 4 Nov 2026, 08:26 UTC. Papers are listed by their metadata only; follow the links to read them. A license shown on an open copy is the license the publisher or repository states for that copy.